| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 12 |
6.76 |
mU/l |
1.29 |
4.49 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67331 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 10 |
6.04 |
mU/l |
1.01 |
3.19 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67334 |
66 |
| SS |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
42.0 days
| 12 |
4.0 |
mU/l |
0.58 |
2.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103326 |
2803 |
| SS |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
84.0 days
| 13 |
5.0 |
mU/l |
0.55 |
2.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103328 |
2803 |
| SS |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
126.0 days
| 12 |
6.0 |
mU/l |
0.58 |
2.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103330 |
2803 |
| SD-Lepem1Sage+/+ |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
42.0 days
| 6 |
14.82 |
mU/l |
3.12 |
7.64 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
104454 |
2949 |
| Crl:WI |
plasma insulin level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood insulin amount |
male |
70.0 days-140.0 days |
8 |
6.24 |
mU/l |
15.6 |
44.12 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
105532 |
3017 |
| GK |
plasma insulin level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood insulin amount |
male |
73.0 days
| 6 |
134.0 |
mU/l |
14.0 |
34.29 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
110615 |
3179 |
| GK/CskCrljCrl |
plasma insulin level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood insulin amount |
male |
168.0 days
| 4 |
12.32 |
mU/l |
1.74 |
3.47 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103090 |
2786 |
| GK/MolTac |
plasma insulin level |
sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
37.96 |
mU/l |
6.5 |
13.0 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103815 |
2864 |
| GK/CskCrlj |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
224.0 days-238.0 days |
10 |
28.6 |
mU/l |
2.6 |
8.22 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
enzyme immunoassay (MMO:0000713) |
|
106892 |
3070 |
| Slc:ZUC-Leprfa+ |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
84.0 days-105.0 days |
9 |
26.0 |
mU/l |
2.6 |
7.8 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
enzyme immunoassay (MMO:0000713) |
slc:zuc-leprfa+ |
108658 |
3070 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 12 |
4.03 |
mU/l |
0.72 |
2.49 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67328 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 20 |
5.47 |
mU/l |
0.72 |
3.22 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67330 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
168.0 days
| 7 |
4.32 |
mU/l |
0.86 |
2.28 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67337 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 10 |
5.32 |
mU/l |
0.72 |
2.28 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67338 |
66 |
| F344/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
male |
119.0 days
| 10 |
43.0 |
mU/l |
4.6 |
14.55 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11613 |
107 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105.0 days
| 10 |
26.52 |
mU/l |
8.06 |
25.49 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68574 |
933 |
| Crl:SD |
plasma insulin level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63.0 days-77.0 days |
8 |
26.0 |
mU/l |
2.0 |
5.66 |
radioimmunoassay |
0.0 |
|
|
|
|
CT |
75850 |
1540 |
| Crl:SD |
plasma insulin level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
days
| |
53.0 |
mU/l |
7.0 |
|
radioimmunoassay |
0.0 |
|
|
|
|
F |
75879 |
1540 |
| Crl:SD |
plasma insulin level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
days
| 8 |
68.0 |
mU/l |
3.0 |
8.49 |
radioimmunoassay |
0.0 |
|
|
|
|
FT |
75880 |
1540 |
| LH/Mav |
plasma insulin level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 10 |
29.17 |
mU/l |
1.42 |
4.49 |
radioimmunoassay |
0.0 |
|
|
|
|
|
102093 |
2645 |
| BN-Chr 13LH/MavRrrc |
plasma insulin level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 9 |
23.41 |
mU/l |
1.88 |
5.64 |
radioimmunoassay |
0.0 |
|
|
|
|
|
102095 |
2645 |
| SR |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
84.0 days
| 11 |
5.0 |
mU/l |
0.6 |
2.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103329 |
2803 |
| SR |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
126.0 days
| 13 |
5.0 |
mU/l |
0.28 |
1.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103331 |
2803 |
| SS/JrHsdMcwi |
plasma insulin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood insulin amount |
male |
42.0 days
| 8 |
7.8 |
mU/l |
0.78 |
2.21 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
100091 |
2418 |
| GK/MolTac |
plasma insulin level |
rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
95.0 days-102.0 days |
3 |
30.42 |
mU/l |
4.2 |
7.28 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103813 |
2864 |
| GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77.0 days
| 10 |
11.44 |
mU/l |
0.16 |
0.52 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
109083 |
3111 |
| SD-Lepem1Sage+/+ |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
42.0 days
| 6 |
18.2 |
mU/l |
0.52 |
1.27 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
104456 |
2949 |
| GK |
plasma insulin level |
controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood insulin amount |
male |
73.0 days
| 6 |
101.0 |
mU/l |
8.0 |
19.6 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
110616 |
3179 |
| GK |
plasma insulin level |
controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood insulin amount |
female |
73.0 days
| 6 |
42.0 |
mU/l |
6.0 |
14.7 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
110618 |
3179 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 18 |
2.73 |
mU/l |
0.43 |
1.83 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67335 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
168.0 days
| 10 |
7.05 |
mU/l |
1.44 |
4.55 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67336 |
66 |
| WKY/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
male |
119.0 days
| 10 |
64.1 |
mU/l |
9.7 |
30.67 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11612 |
107 |
| WKY/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
female |
119.0 days
| 10 |
20.0 |
mU/l |
2.5 |
7.91 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11614 |
107 |
| BN/OrlIcoCrlf |
plasma insulin level |
fasting (for 16 hours) |
Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8. |
blood insulin amount |
not specified |
120.0 days
| 10 |
14.04 |
mU/l |
1.97 |
6.24 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
68985 |
1037 |
| GK/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
male |
60.0 days
| 6 |
18.8 |
mU/l |
2.39 |
5.86 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68778 |
1012 |
| Crl:SD |
plasma insulin level |
controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63.0 days-77.0 days |
9 |
51.0 |
mU/l |
7.0 |
21.0 |
radioimmunoassay |
0.0 |
|
|
|
|
F |
75847 |
1540 |
| BN/NHsdMcwi |
plasma insulin level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 10 |
20.37 |
mU/l |
0.91 |
2.88 |
radioimmunoassay |
0.0 |
|
|
|
|
|
102092 |
2645 |
| SS-Leprem2Mcwi |
plasma insulin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood insulin amount |
male |
42.0 days
| 5 |
122.2 |
mU/l |
2.6 |
5.81 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
100092 |
2418 |
| GK/MolTac |
plasma insulin level |
fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
70.0 days-77.0 days |
6 |
37.18 |
mU/l |
3.93 |
9.62 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103811 |
2864 |
| GK/MolTac |
plasma insulin level |
sodium chloride solution (for 23 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
95.0 days-102.0 days |
4 |
38.74 |
mU/l |
7.28 |
14.56 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103812 |
2864 |
| GK/MolTac |
plasma insulin level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
27.3 |
mU/l |
4.16 |
8.32 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103817 |
2864 |
| GK/MolTac |
plasma insulin level |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
38.22 |
mU/l |
5.2 |
10.4 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103816 |
2864 |
| SD-Lepem1Sage-/- |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
42.0 days
| 6 |
327.08 |
mU/l |
47.32 |
115.91 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
104455 |
2949 |
| WI-Mc4rm1Hubr |
plasma insulin level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood insulin amount |
male |
70.0 days-140.0 days |
8 |
39.0 |
mU/l |
13.0 |
36.77 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
105533 |
3017 |
| GK |
plasma insulin level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood insulin amount |
female |
73.0 days
| 6 |
48.0 |
mU/l |
3.0 |
7.35 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
110617 |
3179 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 15 |
3.45 |
mU/l |
0.72 |
2.79 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67329 |
66 |
| HTG |
plasma insulin level |
fasting (for 16 hours) |
Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8. |
blood insulin amount |
not specified |
120.0 days
| 10 |
13.0 |
mU/l |
2.71 |
8.58 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
68984 |
1037 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
male |
60.0 days
| 6 |
6.4 |
mU/l |
1.12 |
2.74 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68776 |
1012 |
| GK/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
female |
60.0 days
| 6 |
9.1 |
mU/l |
1.38 |
3.38 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68779 |
1012 |
| COP/OlaHsd |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105.0 days
| 10 |
29.12 |
mU/l |
5.72 |
18.09 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68572 |
933 |
| LH-Chr 13BN/Mav |
plasma insulin level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 10 |
30.84 |
mU/l |
1.62 |
5.12 |
radioimmunoassay |
0.0 |
|
|
|
|
|
102094 |
2645 |
| SR |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
42.0 days
| 13 |
4.0 |
mU/l |
0.28 |
1.0 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103327 |
2803 |
| GK |
plasma insulin level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87.0 days
| 6 |
23.4 |
mU/l |
5.2 |
12.74 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
103764 |
2782 |
| Crl:WI |
plasma insulin level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood insulin amount |
male |
168.0 days
| 4 |
14.5 |
mU/l |
4.99 |
9.98 |
plasma insulin analysis |
0.0 |
|
|
|
|
|
103089 |
2786 |
| GK/MolTac |
plasma insulin level |
rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
95.0 days-102.0 days |
4 |
34.58 |
mU/l |
4.68 |
9.36 |
oral glucose tolerance test |
0.0 |
|
|
|
|
|
103814 |
2864 |
| GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77.0 days
| 10 |
11.96 |
mU/l |
0.33 |
1.04 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
109082 |
3111 |
| Crlj:WI |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
224.0 days-238.0 days |
5 |
62.4 |
mU/l |
10.4 |
23.26 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
enzyme immunoassay (MMO:0000713) |
|
108088 |
3070 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 15 |
7.19 |
mU/l |
1.01 |
3.9 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67327 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 12 |
4.32 |
mU/l |
0.43 |
1.5 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67333 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 11 |
3.31 |
mU/l |
0.43 |
1.43 |
intravenous glucose tolerance test |
0.0 |
|
|
|
plasma insulin analysis |
|
67332 |
66 |
| F344/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
female |
119.0 days
| 10 |
17.0 |
mU/l |
2.4 |
7.59 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11615 |
107 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
female |
60.0 days
| 6 |
6.06 |
mU/l |
0.81 |
1.97 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68777 |
1012 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105.0 days
| 10 |
32.5 |
mU/l |
7.54 |
23.84 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
68573 |
933 |
| Crl:SD |
plasma insulin level |
control condition |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63.0 days-77.0 days |
8 |
33.0 |
mU/l |
2.0 |
5.66 |
radioimmunoassay |
0.0 |
|
|
|
|
C |
75848 |
1540 |
| Crl:SD |
plasma insulin level |
controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) |
Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. |
blood insulin amount |
male |
63.0 days-77.0 days |
10 |
32.0 |
mU/l |
4.0 |
12.65 |
radioimmunoassay |
0.0 |
|
|
|
|
FT |
75849 |
1540 |
| Crl:WI(Han) |
plasma insulin level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87.0 days
| 6 |
221.0 |
mU/l |
44.2 |
108.27 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
103761 |
2782 |
| Crl:WI(Han) |
plasma insulin level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87.0 days
| 6 |
213.2 |
mU/l |
46.8 |
114.64 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
103762 |
2782 |
| GK |
plasma insulin level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87.0 days
| 6 |
26.0 |
mU/l |
2.6 |
6.37 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
103763 |
2782 |
| SD-Lepem1Sage-/- |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
42.0 days
| 6 |
971.88 |
mU/l |
99.84 |
244.56 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
|
104457 |
2949 |
| Slc:ZUC-Leprfa-/- |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
84.0 days-105.0 days |
44 |
384.8 |
mU/l |
41.6 |
275.94 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
enzyme immunoassay (MMO:0000713) |
slc:zuc-leprfa-/- |
106938 |
3070 |
| GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77.0 days
| 10 |
11.7 |
mU/l |
0.16 |
0.52 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
109085 |
3111 |